Sudesh Anand Shetty’s Post

In the pharmaceutical world, innovation and regulations reign supreme. We know the struggle: our team specializes in simplifying your contract management process, so you can focus on what matters most. Say goodbye to the headache of navigating complex contracts and compliance standards, and hello to streamlined collaboration. 📃 Understanding pharmaceutical contracts 🔑 Key challenges in contract management ✅ Strategies for enhancing contract management 📊 Best practices for ensuring compliance Check our video recap of DiliTrust's article : https://lnkd.in/eMxgyyCc #Pharma #Contract #Compliance #DiliTrustExec #DigitalTransformation #Solutions

The #pharmaceutical industry operates in one of the most highly regulated environments, making #crossborder #investigations complex. In our latest publication, “Cross-Border Investigations in the Pharma Industry” we explore the intricate challenges of conducting these investigations.   We provide an overview of typical topics of #pharma investigations, including:   ➡️ #bribery and #corruption: Mitigating risks in interactions with healthcare professionals and organizations ➡️ #antitrust and #competition law: Combating practices such as “pay-for-delay”, price fixing and market sharing ➡️ #regulatory compliance: Navigating stringent regulatory frameworks ➡️ #esg: Aligning operations with sustainability and ethical standards ➡️ #IP, #tradesecrets, and #dataprivacy: Safeguarding intellectual property and sensitive information against breaches   Our publication examines the investigation of #transnational allegations within multinational pharmaceutical companies. We cover the triggers for cross-border investigations, the obligations to investigate, the duty to #selfdisclose, and resolving allegations with Swiss authorities. Focusing on the pharmaceutical industry's global operations, we aim to provide critical insights to help organizations navigate this complex legal and regulatory landscape.   Djamila Batache, Daniel Senn and I would like to thank: Prof. Dr. Andrew Garbarski, Carlo Lombardini Alain Macaluso and Laurent Moreillon for the opportunity to publish our article in CEDIDAC - Université de Lausanne's "Développments récents en droit pénal de l'entreprise V". https://lnkd.in/dmvdgft7   #healthcare #compliance

This update affects businesses such as consulting firms, law firms, pharmaceutical firms, real estate businesses, medical companies and any other profession that requires specialized knowledge and skills. If you are planning to register a business that falls under this category, make sure to obtain a proficiency certificate before proceeding to register with the Corporate Affairs Commission. For advice and support for seamless registration, send us a DM or talk to Grace on 0903 408 6536 #Kudination #CACRegistration #NigeriaEntrepreneurs #update

📰 The Legal Status of the "Pharmacien Responsable" a Key Figure in the French Pharmaceutical Industry 👉 Discover our latest article written by Emilie DUCORPS-PROUVOST, Attorney at Law in Labour Law & Partner, and Brigitte Lucas, Attorney at Law in Corporate Law & Partner! 💊 The « Pharmacien Responsable » plays a central role in French pharmaceutical companies. As the guarantor of legal compliance and drug safety, this unique status in Europe comes with specific responsibilities. Why is this role indispensable? ✔ It is required to obtain authorization to operate a pharmaceutical establishment. ✔ It is essential for overseeing pharmaceutical operations and managing risks. ✔ It entails criminal and disciplinary liability for actions carried out under their authority. 📌 In this article, we discuss: ✅ The prerequisites for becoming a Responsible Pharmacist. ✅ Their missions, status, and responsibilities. ✅ The challenges of combining this role with other functions. 🔗 Want to learn more? Read the full article ➡ https://lnkd.in/eSQw54uh #LabourLaw #PharmaceuticalIndustry #PublicHealth #LegalExpertise #Corporatelaw #PassionatelyCommitted ❤

The battle for #intellectualpropertyrights over chlorantraniliprole (CTPR) took a dramatic turn when the Supreme Court of India became involved and sent FMC Corporation's #patentinfringement lawsuits to the High Court of Delhi The controversy emphasizes how crucial it is to safeguard #intellectual propertyrights and handle difficulties in the #pharmaceutical sector. Our area of expertise is to perform #investigations on behalf of prominent entities in order to protect their #intellectualproperty rights. Allow us to help you to safeguard your #inventions Get in touch with us right now! #IntellectualPropertyRights #PatentInfringement #PharmaceuticalSector #Investigations #InventionsProtection #DelhiHighCourt #SupremeCourt #IPProtection #LegalBattle #NatcoPharma #FMCCorporation #LegalExpertise #LegalServices #IntellectualPropertyLaw #InnovationProtection #Intellectual #Property #IntellectualProperty #Patent #Infringement #Pharmaceutical #Sector #Inventions #Protection High Court of Delhi Supreme Court of India #legal #pharma FMC Corporation NATCO Pharma Chander Uday Singh Sai Deepak J Abhishek Singhvi PERFEXIO LEGAL https://lnkd.in/gpMBgGsb

An offence under Section 138, N.I. Act could be compounded under Section 147 thereof, only with the consent of the complainant concerned. #SupremeCourt in A.S. Pharma Pvt. Ltd. vs Nayati Medical Pvt. Ltd. 2024 INSC 690 #sc #supremecourt #legal #legalprofession #legalnews #legalupdate #negotiableinstrumentact

Navigating the complex world of pharmaceutical compliance isn't just about staying on the right side of the law—it's about safeguarding your company’s future. Chapter 4 of our eBook, "Clarity in Compliance," dives deep into the penalties associated with non-compliance in government price reporting and drug price transparency. Whether it's hefty fines, civil and criminal judgments, or even suspension from federal programs, the risks are real and significant. This chapter outlines critical actions to help avoid these pitfalls, ensuring your data submissions are accurate and timely. Download our ebook today:  https://bit.ly/3Lchsya

The #HealthPharm 2024 conference titled "Common Market of the Western Balkans: Business and Legal Platform for Healthcare and Pharmaceuticals" will be held from 9-11 April. Our partner Stefan Petrović will be one of the panelists on the second day of the conference. Stefan will be sharing insights on "How to Buy and Sell Health & Pharma Business." Don't miss out on this informative session! #healthcare #pharmaceuticals

🚀 Ready to tackle the biggest regulatory challenges? Our free webinar is just around the corner! Join our CEO, Dr Graeme Ladds, next week for an essential session in our webinar series: "Biggest Regulatory Challenges and Opportunities to Address for your Company". Explore the critical regulatory issues impacting the pharmaceutical industry and discover effective strategies to navigate them, enhancing your compliance and gaining a strategic advantage. 📅 Date: 26th June 2024 ⏰ Times: 11:00 AM, 3:00 PM, 7:00 PM GMT 📍 Location: Online Webinar (Free) 🗣 Speaker: Dr Graeme Ladds, CEO Why Join? • Gain key insights into regulatory frameworks • Enhance compliance and risk management • Leverage opportunities to gain a competitive advantage Perfect for: • Senior Company Executives (CEO, CFO, Compliance, CSO, Chief Medical Officer) • Regulatory Affairs VP/Director/Managers and Compliance Officers • Quality Assurance Professionals, Procurement • Research and Development Personnel, Clinical Affairs • Legal Advisors 🔗 Register Now: https://lnkd.in/eqmSzTEP Don’t miss this chance to equip yourself with the knowledge to navigate regulatory landscapes effectively. Secure your spot today! #PharSafer #Webinar #Free #BusinessLeadership #ThoughtLeadership #Pharmacovigilance #RegulatoryCompliance #RiskManagement

📢 Excelling in Healthcare & Life Sciences Legal Services | Your Trusted Partner in Puerto Rico At Feldstein Soto-Acabá LLC (FSA), we pride ourselves on being highly qualified legal professionals with a proven track record in the healthcare industry, particularly in the medical devices, pharmaceuticals, and life sciences sectors. Under the leadership of Managing Partner Zarel Soto-Acabá, we have successfully guided manufacturers, pharmaceutical companies, and local distributors through complex regulatory landscapes, ensuring compliance while structuring local and international distribution agreements that align with business goals. With hands-on experience in navigating FDA regulatory matters, including those involving pharmaceuticals, durable medical equipment (DME), and biological products, we offer practical, business-oriented solutions that go beyond legal counsel—we become strategic business partners invested in our clients’ success. Puerto Rico stands as one of the world’s largest manufacturing hubs in the life sciences industry. At FSA, we understand the unique challenges and opportunities this market presents. Our deep business acumen and legal expertise in the medical devices and life sciences arena make us the perfect partner for companies seeking to thrive in this highly regulated environment. Let’s work together to drive growth, compliance, and success in the healthcare industry. #MedicalDevices #LifeSciences #FDACompliance #HealthcareLaw #PuertoRicoBusiness #PharmaceuticalLaw #RegulatoryExperts #FeldsteinSotoAcabá #YourTrustedPartner